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South American blastomycosis is a systemic micosis caused by infection with Paracoccidioides brasiliensis. The most frequently
aﬀected sites are the lower lip buccal mucous membrane, palate, tongue, sublingual region, lymph glands, and lungs. However,
colonic involvement is not a common expression of Paracoccidioidomycosis. We report a case of chronic diarrhea and pancolitis
caused by Paracoccidioidomycosis with fatal outcome.
1.Introduction
South American blastomycosis is a systemic micosis caused
by infection with Paracoccidioides brasiliensis [1], a dimor-
phic fungus, and is endemic in humid tropical and sub-
tropical zones of continental Latin America, Brazil, Per´ u,
and Colombia [2]. The ﬁrst infection usually occurs in the
ﬁrst 2 decades of life through inhalation of the conidia of
the mold into the alveoli. The organisms change to the
yeast form in the lungs and then multiply through budding
and hematogenous dissemination occurs without clinical
manifestations but it can also develop many years later,
depending on multiple factors involved in the host’s immune
response (age, use of immunosuppressive drugs, concurrent
diseases, etc.) [3–5].
In the classical form of the disease, the most frequently
aﬀected sites are the lower lip buccal mucous membrane,
palate, tongue, sublingual region, lymph glands, and lungs
associated with fever, asthenia, and weight loss [6]. Although
adrenal, bone, pancreas, urogenital, spleen, and liver disease
are known, colonic involvement is not a common expression
of Paracoccidioidomycosis [7].
We report a case of chronic diarrhea and pancolitis
caused by Paracoccidioidomycosis.
2.CaseReport
A thirty-nine-year old female patient, from the state of
Chanchamayo, Junin, Peru, with a medical history of
recurrent infections of Strongyloides stercoralis, came to
our hospital with four months of daily bloody mucous
diarrhea associated with abdominal pain and 10 kilogram
weight loss. Diarrhea episodes increased before admis-
sion and she also had mild abdominal colicky pain and
fever. Physical examination revealed a wasted patient with
pale skin and tenderness at the lower abdominal region.
There was no hepatomegaly, splenomegaly, nor palpa-
ble lymph nodes. Relevant blood tests showed anemia
(Hemoglobin 76g/L) low albumin (16g/L). She had over
100 leucocytes and red blood cells per ﬁeld at the stool
examination. Parasitological and stool culture studies were
negatives.
We found incipient lower inﬁltrates at chest X-ray
and Elisa-HIV was negative. Colonoscopy revealed multiple
patchy exudative ulcers from rectum to cecum together with
normal mucosa (Figure 1). Biopsies were taken from the
edges of the ulcerations. Histopathology shown multiple
granulomas and Paracoccidioidomycosis associated with
active inﬂammation (Figure 2).2 Case Reports in Medicine
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Figure 1: (a) Arrow showing patchy ulcer surround by normal mucosa. (b) Giant exudative colonic ulcer. (c) Intense inﬂammatory stenotic
ulcer.
Sputum and urine samples for Paracoccidioidomycosis
andbloodtestforHTLV-1werepositive.Thepatientreceived
AmphotericinBasinitialtreatmentwithpartialresponsebut
developed a stroke and died from sepsis.
3. Discussion
Paracoccidioidomycosis (PCM) or South American blasto-
mycosis is a granulomatous, chronic, infectious, subacute, or
seldom acute disease, caused by the fungus Paracoccidioides
brasiliensis [2]. It is characterized by a polymorphism of
lesions and can aﬀect any organ, but it is usually found in
the skin, lungs; the oral and nasal mucous membranes [3, 4].
Eighty to ninety percent of aﬀected individuals are
men between 29 and 40 years old, predominantly rural
workers, with a male/female ratio of 15 : 1 [4]. The biggest
risk factors for acquisition of the infection are activities
related to the handling of soil contaminated by the fungus,
as in agricultural activities, earth moving, gardening, and
transport of vegetable products.
Intestinal involvement is mostly through hematogenous
spread but it may occur by ingestion. Clinical spectrum
range from abdominal pain, constipation, diarrhea to acute
abdomen secondary to appendicitis or intestinal occlusion as
a result of the increase in lymph nodes [8, 9].
The disease can present with long latency periods and
somenoautochthonouscasescanevendevelopmorethan30
yearsaftertheindividualhaslefttheendemicarea.Moreover,
intestinal form has and incidence of 2.7% to 28.4% of
autopsies [10].
The main alterations in the intestinal tract are found in
the small and large bowel, in segments rich in lymphoid tis-
sue, such as terminal ileum, appendix, and right hemicolon
[8].
Although the intestinal form has nonspeciﬁc radio-
graphic aspects, abdominal lymph node calciﬁcations and
annular stenosis are suggestive of the disease [8]. Colitis
and colonic ulcers are diﬃcult to diﬀerentiate from other
fungal infection, tuberculosis, inﬂammatory bowel disease,
and even colon cancer [7, 8].Case Reports in Medicine 3
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Figure 2: (a) H&E Granulomatous inﬁltration and necrosis. (b) H&E Giant cell containing multiples PCM. (c) PAS Intra and extracellular
PCM.
Diagnosis is suspected on clinical grounds, epidemio-
logic history, and imaging studies and conﬁrmed by the
identiﬁcation of the fungus by culture, direct mycologic, or
histopathologic examination [3].
Typical histology shows granulomas rich in epithelioid
and giant cells, some containing variable amounts of para-
sites. The ﬁnding of a double wall parasite with simple or
multiple gemmulation is diagnostic [3, 4].
PCM treatment includes the use of antifungal drugs,
nutritional support, treatment of the eventual sequelae and
comorbidities, and the prevention of opportunist diseases
[11].
Before antifungal drugs were available, pharmacologic
treatment was based on sulfonamides (sulfamethoxazole-
trimethoprim) [7]. Currently amphotericin B (AmB), and
imidazolic derivates, such as, itraconazole, and ﬂuconazole
are the preferred agents [4, 11].
According to the latest guidelines [11, 12]. Patients with
severe disseminated disease should be treated with AmB
deoxycholate or a lipid formulation of AmB (total dose
greater than 30mg/kg) and mild to moderate disseminated
blastomycosis that does not involve the CNS should be
treated with itraconazole (200 or 400mg orally daily).
No consensus exists on the duration of treatment and
criteria for its termination have not been established [4].
Recurrences are not uncommon, especially in cases of
treatment abandonment. If clinical manifestations reappear
or fungal structures of P. brasiliensis are isolated, a new
treatment course should be undertaken [4].
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